Sequester Could Gum Up FDA Drug, Device Reviews

Law360, New York (August 10, 2012, 5:51 PM EDT) -- A federal sequester slashing 8 percent of the U.S. Food and Drug Administration's budget could be devastating for the agency and the industry that relies on it, potentially forcing layoffs and slowing down drug and device reviews as the FDA tries to reach its user fee goals.

Unless Congress moves to avert the federal sequester before January by finding $1.2 trillion in deficit reduction or, more likely, by pushing the deadline back, each federal agency will have to cut its budget by an estimated 7.8 percent,...
To view the full article, register now.